{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:38Z","timestamp":1792699958492,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.riam.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:09:52Z","timestamp":1694646592000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature"],"prefix":"10.1016","volume":"40","author":[{"given":"Muhammed Cihan","family":"I\u015f\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O\u011fuz","family":"Karc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fen","family":"Haz\u0131rolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolunay","family":"G\u00fclmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ruhi","family":"Onur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Mahir","family":"Kunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Metan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2023.05.001_bib0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.idc.2020.02.004","article-title":"Infectious complications of immune checkpoint inhibitors","volume":"34","author":"Abers","year":"2020","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.riam.2023.05.001_bib0120","series-title":"Method for the determination of broth dilution minimun inhibitory concentrations of antifungal agents for conidia forming moulds. EUCAST antifungal MIC method for moulds [Internet]","author":"Arendrup","year":"2020"},{"key":"10.1016\/j.riam.2023.05.001_bib0125","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/1751-7915.12182","article-title":"Mutualistic interaction between Salmonella enterica and Aspergillus niger and its effects on Zea mays colonization","volume":"7","author":"Balbontin","year":"2014","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.riam.2023.05.001_bib0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40588-020-00154-4","article-title":"Fungal infections associated with the use of novel immunotherapeutic agents","volume":"7","author":"Bernardes","year":"2020","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.riam.2023.05.001_bib0135","doi-asserted-by":"crossref","first-page":"e25553","DOI":"10.1371\/journal.pone.0025553","article-title":"Salmonella biofilm formation on Aspergillus niger involves cellulose\u2013chitin interactions","volume":"6","author":"Brandl","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.riam.2023.05.001_bib0140","series-title":"Posaconazole: rationale for the EUCAST clinical breakpoints, version 3.0. European Committee on Antimicrobial Susceptibility Testing [Internet]","author":"EUCAST","year":"2020"},{"key":"10.1016\/j.riam.2023.05.001_bib0145","series-title":"Breakpoint tables for interpretation of MICs for antifungal agents. European Committee on Antimicrobial Susceptibility Testing [Internet]","author":"EUCAST","year":"2022"},{"key":"10.1016\/j.riam.2023.05.001_bib0150","series-title":"Voriconazole: rationale for the EUCAST clinical breakpoints, version 4.0. European Committee on Antimicrobial Susceptibility Testing [Internet]","author":"EUCAST","year":"2020"},{"key":"10.1016\/j.riam.2023.05.001_bib0155","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. European Committee on Antimicrobial Susceptibility Testing [Internet]","author":"EUCAST","year":"2021"},{"key":"10.1016\/j.riam.2023.05.001_bib0160","series-title":"Itraconazole: rationale for the EUCAST clinical breakpoints, version 3.0. European Committee on Antimicrobial Susceptibility Testing [Internet]","author":"EUCAST","year":"2021"},{"key":"10.1016\/j.riam.2023.05.001_bib0165","first-page":"2178925","article-title":"Invasive aspergillosis in a patient with stage III (or 3a or 3b) non-small-cell lung cancer treated with durvalumab","volume":"2019","author":"Gupta","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.riam.2023.05.001_bib0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/17843286.2019.1629078","article-title":"Severe pulmonary infections complicating nivolumab treatment for lung cancer: a report of two cases","volume":"75","author":"Inthasot","year":"2020","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.riam.2023.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/1759-7714.13422","article-title":"Opportunistic infections complicating immunotherapy for non-small cell lung cancer","volume":"11","author":"Liu","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.riam.2023.05.001_bib0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/1759-7714.13313","article-title":"Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections","volume":"11","author":"Lu","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.riam.2023.05.001_bib0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jinf.2019.10.022","article-title":"Necrotizing soft tissue invasive aspergillosis in a cancer patient treated with immunosuppressants due to checkpoint inhibitor-induced hepatitis","volume":"80","author":"Malek","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.riam.2023.05.001_bib0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/thoraxjnl-2021-217260","article-title":"Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy","volume":"77","author":"Morelli","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.riam.2023.05.001_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11046-018-0291-4","article-title":"Invasive pulmonary aspergillosis complicated by carbapenem-resistant Pseudomonas aeruginosa infection during pembrolizumab immunotherapy for metastatic lung adenocarcinoma: case report and review of the literature","volume":"184","author":"Oltolini","year":"2019","journal-title":"Mycopathologia"},{"key":"10.1016\/j.riam.2023.05.001_bib0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3855\/jidc.7069","article-title":"Salmonella pneumonia complicated with encysted empyema in an immunocompromised youth: case report and literature review","volume":"10","author":"Saeed","year":"2016","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.riam.2023.05.001_bib0205","doi-asserted-by":"crossref","unstructured":"Taima K, Tanaka H, Itoga M, Ishioka Y, Kurose A, Tasaka S. Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab. Respirol Case Rep. 2020;8:e00580.","DOI":"10.1002\/rcr2.580"},{"key":"10.1016\/j.riam.2023.05.001_bib0210","doi-asserted-by":"crossref","first-page":"e00289","DOI":"10.1002\/rcr2.289","article-title":"Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab","volume":"6","author":"Uchida","year":"2018","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.riam.2023.05.001_bib0215","first-page":"101627","article-title":"A case of non-neutropenic invasive pulmonary aspergillosis under immune checkpoint inhibitor therapy for malignant melanoma","volume":"37","author":"Uchida","year":"2022","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.riam.2023.05.001_bib0220","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140623000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140623000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:07:41Z","timestamp":1761106061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140623000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":22,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1130140623000098"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2023.05.001","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}